SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2

Human Molecular Genetics

Volumn 25, Issue 18, 2016, Pages 3925-3936

  Fogarty, Elizabeth A ^a   Brewer, Megan H ^b   Rodriguez Molina, Jose F ^c   Law, William D ^b   Ma, Ki H ^c   Steinberg, Noah M ^b   Svaren, John ^d,e   Antonellis, Anthony ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MTMR2 PROTEIN; PROTEIN; RENILLA LUCIFERIN 2 MONOOXYGENASE; RNA 18S; RNA ISOFORM; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG; MTMR2 PROTEIN, HUMAN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; SOX10 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL VIABILITY; COMPARATIVE STUDY; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; ENDOPLASMIC RETICULUM; ENHANCER REGION; ENZYME ACTIVITY; EXON; EXPRESSION VECTOR; FEMALE; FLUORESCENCE MICROSCOPY; GENE; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOTONEURON; MOUSE; MTMR2 GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL CULTURE; SEQUENCE ANALYSIS; STOP CODON; TRANSCRIPTION INITIATION SITE; TRANSIENT TRANSFECTION; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEREDITARY MOTOR SENSORY NEUROPATHY; METABOLISM; MUTATION; MYELIN SHEATH; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; REGULATORY SEQUENCE; SCHWANN CELL;

ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE; MOTOR NEURONS; MUTATION; MYELIN SHEATH; PERIPHERAL NERVES; PROMOTER REGIONS, GENETIC; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RATS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SCHWANN CELLS; SOXE TRANSCRIPTION FACTORS;

EID: 85014346728     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw233     Document Type: Article

References (50)

1. Skre, H. (1974) Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet., 6, 98-118.
2. Dyck, P.J. and Lambert, E.H. (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch. Neurol., 18, 619-625.
3. Dyck, P.J. and Lambert, E.H. (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch. Neurol., 18, 603-618.
4. Monk, K.R., Feltri, M.L. and Taveggia, C. (2015) New insights on Schwann cell development. Glia, 63, 1376-1393.
5. Harding, A.E. and Thomas, P.K. (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain, 103, 259-280.
6. Brennan, K.M., Bai, Y. and Shy, M.E. (2015) Demyelinating CMT-what's known, what's new and what's in store? Neurosci. Lett., 596, 14-26.
7. Su, Y., Brooks, D.G., Li, L., Lepercq, J., Trofatter, J.A., Ravetch, J.V. and Lebo, R.V. (1993) Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients. Proc. Natl Acad. Sci. U SA, 90, 10856-10860.
8. Warner, L.E., Mancias, P., Butler, I.J., McDonald, C.M., Keppen, L., Koob, K.G. and Lupski, J.R. (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet., 18, 382-384.
9. Bolino, A., Muglia, M., Conforti, F.L., LeGuern, E., Salih, M.A., Georgiou, D.M., Christodoulou, K., Hausmanowa-Petrusewicz, I., Mandich, P., Schenone, A., et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet., 25, 17-19.
10. Gambardella, A., Bono, F., Muglia, M., Valentino, P. and Quattrone, A. (1999) Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B). Ann. N Y Acad. Sci., 883, 47-55.
11. Bolis, A., Coviello, S., Bussini, S., Dina, G., Pardini, C., Previtali, S.C., Malaguti, M., Morana, P., Del Carro, U., Feltri, M.L., et al. (2005) Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-Tooth type 4B1 neuropathy with myelin outfoldings. J. Neurosci., 25, 8567-8577.
12. Patzig, J., Jahn, O., Tenzer, S., Wichert, S.P., de Monasterio-Schrader, P., Rosfa, S., Kuharev, J., Yan, K., Bormuth, I., Bremer, J., et al. (2011) Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J. Neurosci., 31, 16369-16386.
13. Chojnowski, A., Ravise, N., Bachelin, C., Depienne, C., Ruberg, M., Brugg, B., Laporte, J., Baron-Van Evercooren, A. and LeGuern, E. (2007) Silencing of the Charcot-Marie-Tooth associated MTMR2 gene decreases proliferation and enhances cell death in primary cultures of Schwann cells. Neurobiol. Dis., 26, 323-331.
14. Vaccari, I., Dina, G., Tronchere, H., Kaufman, E., Chicanne, G., Cerri, F., Wrabetz, L., Payrastre, B., Quattrini, A., Weisman, L.S., et al. (2011) Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies. PLoS Genet., 7, e1002319.
15. Berger, P., Bonneick, S., Willi, S., Wymann, M. and Suter, U. (2002) Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum. Mol. Genet., 11, 1569-1579.
16. Begley, M.J. and Dixon, J.E. (2005) The structure and regulation of myotubularin phosphatases. Curr. Opin. Struct.Biol., 15, 614-620.
17. Bolis, A., Zordan, P., Coviello, S. and Bolino, A. (2007) Myotubularin-related (MTMR) phospholipid phosphatase proteins in the peripheral nervous system. Mol. Neurobiol., 35, 308-316.
18. Previtali, S.C., Zerega, B., Sherman, D.L., Brophy, P.J., Dina, G., King, R.H., Salih, M.M., Feltri, L., Quattrini, A., Ravazzolo, R., et al. (2003) Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve. Hum. Mol. Genet., 12, 1713-1723.
19. Bremer, M., Frob, F., Kichko, T., Reeh, P., Tamm, E.R., Suter, U. and Wegner, M. (2011) Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia, 59, 1022-1032.
20. Antonellis, A. and Green, E.D. (2008) Willard, H. and Ginsburg, G. (eds.), In Genomic and Personalized Medicine. Academic Press, Salt Lake City, in press., pp. 120-130.
21. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M. and Haussler, D. (2002) The human genome browser at UCSC. Genome Res., 12, 996-1006.
22. Goda, S., Hammer, J., Kobiler, D. and Quarles, R.H. (1991) Expression of the myelin-associated glycoprotein in cultures of immortalized Schwann cells. J. Neurochem., 56, 1354-1361.
23. Hai, M., Muja, N., DeVries, G.H., Quarles, R.H. and Patel, P.I. (2002) Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J. Neurosci. Res., 69, 497-508.
24. Hodonsky, C.J., Kleinbrink, E.L., Charney, K.N., Prasad, M., Bessling, S.L., Jones, E.A., Srinivasan, R., Svaren, J., McCallion, A.S. and Antonellis, A. (2012) SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoter. Mol. Cell Neurosci., 49, 85-96.
25. Antonellis, A., Bennett, W.R., Menheniott, T.R., Prasad, A.B., Lee-Lin, S.Q., Green, E.D., Paisley, D., Kelsh, R.N., Pavan, W.J. and Ward, A. (2006) Deletion of long-range sequences at Sox10 compromises developmental expression in a mouse model of Waardenburg-Shah (WS4) syndrome. Hum. Mol. Genet., 15, 259-271.
26. Salazar-Grueso, E.F., Kim, S. and Kim, H. (1991) Embryonic mouse spinal cord motor neuron hybrid cells. Neuroreport., 2, 505-508.
27. Bolino, A., Marigo, V., Ferrera, F., Loader, J., Romio, L., Leoni, A., Di Duca, M., Cinti, R., Cecchi, C., Feltri, M.L., et al. (2002) Molecular characterization and expression analysis of Mtmr2, mouse homologue of MTMR2, the Myotubularinrelated 2 gene, mutated in CMT4B. Gene, 283, 17-26.
28. Yaffe, D. and Saxel, O. (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature, 270, 725-727.
29. Suter, U., Snipes, G.J., Schoener-Scott, R., Welcher, A.A., Pareek, S., Lupski, J.R., Murphy, R.A., Shooter, E.M. and Patel, P.I. (1994) Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J. Biol. Chem., 269, 25795-25808.
30. Franklin, N.E., Taylor, G.S. and Vacratsis, P.O. (2011) Endosomal targeting of the phosphoinositide 3-phosphatase MTMR2 is regulated by an N-terminal phosphorylation site. J. Biol. Chem., 286, 15841-15853.
31. Lopez-Anido, C., Sun, G., Koenning, M., Srinivasan, R., Hung, H.A., Emery, B., Keles, S. and Svaren, J. (2015) Differential Sox10 genomic occupancy in myelinating glia. Glia, 63, 1897-1914.
32. Jones, E.A., Jang, S.W., Mager, G.M., Chang, L.W., Srinivasan, R., Gokey, N.G., Ward, R.M., Nagarajan, R. and Svaren, J. (2007) Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol., 3, 377-387.
33. Srinivasan, R., Sun, G., Keles, S., Jones, E.A., Jang, S.W., Krueger, C., Moran, J.J. and Svaren, J. (2012) Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve. Nucleic Acids Res., 40, 6449-6460.
34. Harley, V.R., Lovell-Badge, R. and Goodfellow, P.N. (1994) Definition of a consensus DNA binding site for SRY. Nucleic Acids Res., 22, 1500-1501.
35. Peirano, R.I. and Wegner, M. (2000) The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res., 28, 3047-3055.
36. Stolt, C.C. and Wegner, M. (2010) SoxE function in vertebrate nervous system development. Int. J. Biochem. Cell Biol., 42, 437-440.
37. Inoue, K., Khajavi, M., Ohyama, T., Hirabayashi, S., Wilson, J., Reggin, J.D., Mancias, P., Butler, I.J., Wilkinson, M.F., Wegner, M., et al. (2004) Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat. Genet., 36, 361-369.
38. Laporte, J., Blondeau, F., Buj-Bello, A. and Mandel, J.L. (2001) The myotubularin family: from genetic disease to phosphoinositide metabolism. Trends Genet., 17, 221-228.
39. Weider, M., Reiprich, S. and Wegner, M. (2013) Sox appeal-Sox10 attracts epigenetic and transcriptional regulators in myelinating glia. Biol. Chem., 394, 1583-1593.
40. Houlden, H., Girard, M., Cockerell, C., Ingram, D., Wood, N.W., Goossens, M., Walker, R.W. and Reilly, M.M. (2004) Connexin 32 promoter P2 mutations: a mechanism of peripheral nerve dysfunction. Ann. Neurol., 56, 730-734.
41. Antonellis, A., Dennis, M.Y., Burzynski, G., Huynh, J., Maduro, V., Hodonsky, C.J., Khajavi, M., Szigeti, K., Mukkamala, S., Bessling, S.L., et al. (2010) A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo. PLoS One, 5, e14346.
42. Brewer, M.H., Ma, K.H., Beecham, G.W., Gopinath, C., Baas, F., Choi, B.O., Reilly, M.M., Shy, M.E., Zuchner, S., Svaren, J., et al. (2014) Haplotype-specific modulation of a SOX10/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2. Hum. Mol. Genet., 23, 5171-5187.
43. Kurihara, T., Monoh, K., Sakimura, K. and Takahashi, Y. (1990) Alternative splicing of mouse brain 2', 3'-cyclic-nucleotide 3'-phosphodiesterase mRNA. Biochem. Biophys. Res. Commun., 170, 1074-1081.
44. Söhl, G., Gillen, C., Bosse, F., Gleichmann, M., Müller, H.W. and Willecke, K. (1996) A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur. J. Cell Biol., 69, 267-275.
45. Guo, F., Chiang, M.Y., Wang, Y. and Zhang, Y.Z. (2008) An in vitro recombination method to convert restriction-and ligation-independent expression vectors. Biotechnol J., 3, 370-377.
46. Li, J.C., Samy, E.T., Grima, J., Chung, S.S., Mruk, D., Lee, W.M., Silvestrini, B. and Cheng, C.Y. (2000) Rat testicular myotubularin, a protein tyrosine phosphatase expressed by Sertoli and germ cells, is a potential marker for studying cell-cell interactions in the rat testis. J. Cell Physiol., 185, 366-385.
47. Ng, A.A., Logan, A.M., Schmidt, E.J. and Robinson, F.L. (2013) The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression. Hum. Mol. Genet., 22, 1493-1506.
48. Gokey, N.G., Srinivasan, R., Lopez-Anido, C., Krueger, C. and Svaren, J. (2012) Developmental regulation of microRNA expression in Schwann cells. Mol. Cell Biol., 32, 558-568.
49. Schmidt, D., Wilson, M.D., Spyrou, C., Brown, G.D., Hadfield, J. and Odom, D.T. (2009) ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods, 48, 240-248.
50. Umlauf, D., Goto, Y. and Feil, R. (2004) Site-specific analysis of histone methylation and acetylation. Methods Mol. Biol., 287, 99-120.